Research New Research Reveals How Seminal Fluid Actively Amplifies Mpox InfectivityGlobal Biodefense StaffSeptember 12, 2026
Defense + Military Pentagon Pain-Medication EUA Pathway Opens Amid Ongoing Iran ConflictGlobal Biodefense StaffSeptember 4, 2026
Medical Countermeasures GSK’s mRNA Flu Vaccine Heads to Phase IIIGlobal Biodefense StaffSeptember 2, 2026
New CDC-Backed Study Quantifies COVID-19 Vaccine’s Transmission-Blocking Effect Medical Countermeasures May 16, 2026 …
ARPA-H Bets Big on Ambient Storage for Cell Therapies, Launching Program to Break the Cold Chain Medical Countermeasures May 15, 2026 …
New Insights Into Tularemia Pathogen May Inform Next-Generation Medical Countermeasures Medical Countermeasures May 14, 2026 …
BioNTech’s Manufacturing Retreat Signals a Broader Erosion of mRNA Vaccine Capacity Medical Countermeasures May 5, 2026 …
mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1 Medical Countermeasures April 26, 2026 …
UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next Pandemic Medical Countermeasures April 23, 2026 …
When Mpox Strikes the Eye: A Case for Combination Antiviral Therapy Medical Countermeasures April 16, 2026 …
Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense Stockpiles Medical Countermeasures March 25, 2026 …
U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 Million Industry News March 25, 2026 …
UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences Fund Medical Countermeasures September 29, 2025 …
U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure Contracts Contracts + Grants September 23, 2025 …
New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum Antivirals Pathogens September 23, 2025 …
Building Europe’s Health Shield: New EU4Health Calls Advance Medical Countermeasures and Diagnostics CBRNE September 22, 2025 …
New Antibiotic Options Show Promise Against Biothreat Pathogens Antimicrobial Resistance September 12, 2025 …
Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense Preparedness Medical Countermeasures September 9, 2025 …
New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis Bacterium Medical Countermeasures September 5, 2025 …
Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia Vaccine Medical Countermeasures August 11, 2025 …
Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind Challenge Medical Countermeasures July 28, 2025 …
